ERCC1 and non-small cell lung carcinoma: A novel pharmaceutical nanoformulation based on DMC-loaded amphiphilic chitosan nanomatrix was designed to investigate the cellular internalization and inhibitory effect on cisplatin-induced TP and ERCC1 overexpression in NSCLC.